Clinical Trial Update: Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating perioperative therapy for resectable and borderline-resectable pancreatic adenocarcinoma with molecular correlates has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Academic Thoracic Oncology Medical Investigators Consortium | Conditions: Pancreatic Cancer, Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-02-14